Ask AI

APPlexus Hot Topics 2025

Stream on-demand webcasts with accompanying downloadable slides and read expert-written ClinicalThought commentaries from APPlexus Hot Topics 2025, designed and tailored specifically for advanced practice providers. Learn about the latest updates in the management of breast cancer with CDK4/6 inhibitors and antibody–drug conjugates and new strategies using targeted therapies for CLL/SLL and bispecific antibodies for DLBCL and for managing adverse events associated with BTK inhibitor therapy in patients with lymphoma.

Share

Program Content

Activities

APP Guide CDK46i Therapy
The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 19, 2025

Managing CDKi Therapy in HR Positive HER2 Negative BC
The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 03, 2025

Expires: April 02, 2026

Activities

APPLexus CLL/SLL
Optimizing CLL/SLL Care: Expert Strategies for APPs to Integrate New Targeted Therapies and Practice-Changing Evidence
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 19, 2025

Expires: April 01, 2026

Optimizing CLL SLL Care
Optimizing CLL/SLL Care: Expert Strategies for APPs to Integrate New Targeted Therapies and Practice-Changing Evidence
Video
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2025

Expires: March 29, 2026

Activities

ADCs in Breast Cancer
Maximizing Efficacy and Minimizing Toxicities With Antibody–Drug Conjugates in Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2025

ADCs in Breast Cancer
Maximizing Efficacy and Minimizing Toxicities With Antibody–Drug Conjugates in Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2025

Expires: March 31, 2026

Activities

BTK Inhibitor Therapy in Lymphoma
The APP’s Guide to Patient-Centered Management of BTK Inhibitor Therapy in Lymphoma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 18, 2025

BTKi Therapy in Lymphoma
The APP’s Guide to Patient-Centered Management of BTK Inhibitor Therapy in Lymphoma
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2025

Expires: March 28, 2026

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC.

Supporters

The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer

Supported by an educational grant from Lilly.

Optimizing CLL/SLL Care: Expert Strategies for APPs to Integrate New Targeted Therapies and Practice-Changing Evidence

Supported by an educational grant from Lilly.

Maximizing Efficacy and Minimizing Toxicities With Antibody–Drug Conjugates in Breast Cancer

Supported by an educational grant from Gilead Sciences, Inc.

The APP’s Guide to Patient-Centered Management of BTK Inhibitor Therapy in Lymphoma

Supported by an educational grant from BeOne Medicines.

The How and Why of Bispecific Antibodies for R/R DLBCL: Best Practices for Exemplary Care

Supported by an educational grant from Genmab US, Inc.

BeOne Medicines

Genmab US, Inc.

Gilead Sciences, Inc.

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner